• Intrinsic function of the peptidylarginine deiminase PADI4 is dispensable for normal haematopoiesis 

  Young, C; Russell, JR; Van de Lagemaat, LN; Lawson, H; Mapperley, C; Kranc, KR; Christophorou, MA (2022-06)

• Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma 

  Larrea, E; Fernandez-Mercado, M; Guerra-Assuncao, JA; Wang, J; Goicoechea, I; Gaafar, A; Ceberio, I; Lobo, C; Okosun, J; Enright, AJ (2020-11)

• Genome-wide association study identifies susceptibility loci for acute myeloid leukemia 

  Lin, W-Y; Fordham, SE; Hungate, E; Sunter, NJ; Elstob, C; Xu, Y; Park, C; Quante, A; Strauch, K; Gieger, C (2021-10-29)

• Targeting the lysine-specific demethylase 1 rewires kinase networks and primes leukemia cells for kinase inhibitor treatment 

  Pedicona, F; Casado, P; Hijazi, M; Gribben, JG; Rouault-Pierre, K; Cutillas, PR (2022-04-19)

• CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation 

  Lawson, H; van de Lagemaat, LN; Barile, M; Tavosanis, A; Durko, J; Villacreces, A; Bellani, A; Mapperley, C; Georges, E; Martins-Costa, C (2021-11-09)

• Impact of COVID-19 in patients with lymphoid malignancies. 

  Riches, JC (2021-05-25)

  The first cases of coronavirus disease 2019 (COVID-19) were detected in Wuhan, China, in December 2019. Since this time a concerted global effort of research and observational data gathering has meant that a great deal has ...

• Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients 

  Caldwell, L; Bapat, A; Drumright, LN; Lambourne, J; Jimenez-England, FG; Aries, J; Eccersley, L; Hallam, S; Montoto, S; Oakervee, H (2021-01-08)

• Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets 

  Khorsandi, SE; Dokal, AD; Rajeeve, V; Britton, DJ; Illingworth, MS; Heaton, N; Cutillas, PR (2021-11)

• Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs 

  Gerdes, H; Casado, P; Dokal, A; Hijazi, M; Akhtar, N; Osuntola, R; Rajeeve, V; Fitzgibbon, J; Travers, J; Britton, D (2021-03-25)

• Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia 

  Bloehdorn, J; Braun, A; Taylor-Weiner, A; Jebaraj, BMC; Robrecht, S; Krzykalla, J; Pan, H; Giza, A; Akylzhanova, G; Holzmann, K (Springer Science and Business Media LLC, 2021-12)

  Knowledge of the genomic landscape of chronic lymphocytic leukemia (CLL) grows increasingly detailed, providing challenges in contextualizing the accumulated information. To define the underlying networks, we here perform ...

• Expression patterns of CD180 in the lymph nodes of patients with chronic lymphocytic leukaemia 

  Edwards, K; Zaitseva, K; Sayed, U; Volpi, EV; Nathwani, A; Gribben, JG; Lydyard, P; Krysov, S; Porakishvili, N (Wiley, 2021-07-05)

• The Role of Metabolism in the Development of Personalized Therapies in Acute Myeloid Leukemia 

  Dembitz, V; Gallipoli, P (Frontiers Media, 2021-05-19)

  Despite significant recent advances in our understanding of the biology and genetics of acute myeloid leukemia (AML), current AML therapies are mostly based on a backbone of standard chemotherapy which has remained mostly ...

• Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis 

  Stojic, L; Lun, ATL; Mangeri, J; Mascalchi, P; Quarantotti, V; Barr, AR; Bakal, C; Marioni, JC; Gergely, F; Odom, DT (Oxford University Press, 2018-07-06)

• Spotlight On Early Career Researchers: an interview with Lovorka Stojic 

  Lee, J-E; Stojic, L (Springer Nature, 2019-06-14)

• The Role of Csmd1 during Mammary Gland Development. 

  Burgess, SJ; Gibbs, H; Toomes, C; Coletta, PL; Bell, SM (MDPI, 2021-01-26)

  The Cub Sushi Multiple Domains-1 (CSMD1) protein is a tumour suppressor which has been shown to play a role in regulating human mammary duct development in vitro. CSMD1 knockdown in vitro demonstrated increased cell ...

• Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients 

  Vijenthira, A; Gong, IY; Fox, TA; Booth, S; Cook, G; Fattizzo, B; Martin-Moro, F; Razanamahery, J; Riches, JC; Zwicker, J (2020-12-17)

• In Chronic Lymphocytic Leukemia Delta CT7544-7545 Mutant NOTCH1 Maintains Transcription Factor Activity with Longer Lasting Effects Due to Slower Degradation 

  Edelmann, J; Klymenko, T; Lu, C; Vilventhraraja, E; Estenfelder, S; Tausch, E; Beers, SA; Stilgenbauer, S; Cragg, MS; Ivanov, A (2016-12-02)

• Multiplatform Profiling Characterizes Functional Networks in Genomically Stable and Instable Chronic Lymphocytic Leukemia 

  Bloehdorn, J; Braun, A; Jebaraj, BMC; Taylor-Weiner, A; Robrecht, S; Krzykalla, J; Holzmann, K; Johnston, H; Klymenko, T; Eichhorst, B (2020-11-05)

• Anti-CD20 Monoclonal Antibodies Hijack the B-Cell Receptor Signaling Cascade Thereby Activating the NOTCH1 Signaling Pathway 

  Edelmann, J; Britton, DJ; Vilventhraraja, E; Dokal, A; Holzmann, K; Cragg, MC; Braun, A; Cutillas, P; Gribben, JG (2018-11-29)

• NUCLEAR LAMINA REGULATES SOMATIC HYPERMUTATION AND PROGRESSION OF B CELL MALIGNANCIES 

  Klymenko, T; Bloehdorn, J; Bahlo, J; Robrecht, S; Wang, J; Fischer, K; Akylzhanova, G; Edelmann, J; Estenfelder, S; Strefford, J (2017-06-26)

View more